An interventional study of High Flow Oxygen Therapy (HFOT) in Respiratory Failure and Hypercapnic Acidosis, sponsored by Cardarelli Hospital. Not yet recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-13.
Sponsored by Cardarelli Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 112 studies in Respiratory Insufficiency with a site in Italy — 27 open to participants now, 28 under way, 2 of them phase 3. Respiratory Insufficiency · Italy.
Among the 112 studies in Respiratory Insufficiency with a site in Italy, this one is the 26th largest by planned enrollment of the 65 interventional ones that give a count, is one of 12 that started in 2024, is one of 51 with no phase, reaches primary completion later than 7 of the 27 other live ones, and was the 73rd registered.
1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.
Browse Respiratory Insufficiency studies →27 of the 112 studies in Respiratory Insufficiency with a site in Italy are open now. Recruiting first, the newest first:
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Sites in Italy
Ages 18+
Istituto Clinico Humanitas · Sites in Italy
Ages 18+
Centre for Medical Sciences · Sites in Italy
Ages 18+
Università Vita-Salute San Raffaele · Sites in Italy
Ages 65+ · Healthy volunteers
Istituto Giannina Gaslini · Sites in Italy
Ages 18+ · Men only
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
112 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 12 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 60 across 861 interventional studies indexed under Respiratory Insufficiency.
Median enrollment 55 across the 65 interventional studies, 93 across the 45 observational. Of the 65 that completed or were terminated, 4 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 112 have an industry lead sponsor. The 10 most frequent:
Cardarelli Hospital is the lead sponsor of 9 studies on the registry; 6 are open to participants now.
Cardarelli Hospital has 1 study filed under Respiratory Insufficiency — fewer than ten, so there is no comparison to draw.
7 of the studies in Respiratory Insufficiency with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07098611Medipol UniversityA New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score | 2026-12-30 |
| NCT06511583Azienda Ospedaliero-Universitaria CareggiFBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department | 2027-02-05 |
| NCT07175194Istituto Clinico HumanitasAssociation Between EIT and CT During PEEP Titration in Patients With Acute Respiratory Failure | 2027-03 |
| NCT05440851University Health Network, TorontoPlatform of Randomized Adaptive Clinical Trials in Critical Illness | 2027-03-31 |
| NCT06001645Università Vita-Salute San RaffaeleLaboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS) | 2027-04 |
Add all 7 to your calendar (.ics) → With an account.
Among the 112 studies in Respiratory Insufficiency with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A reduction of peripheral oxygen saturation (SpO2) commonly occurs during bronchoscopy and may be associated with both respiratory and cardiac adverse events. The type of breathing assistance that should be delivered to patients, in order to treat and/or to prevent acute respiratory failure, during or after bronchoscopy, is not universally standardized; studies comparing the impact of different respiratory supports on patient's outcome and on hospital resource use are very few. the risk of respiratory failure rises according to the type of procedure (i.e., increased risk with broncho-alveolar lavage and trans-bronchial lung biopsy) and to the use of sedative drugs. Conventional oxygen therapy with nasal cannula, continuous positive airway pressure and non-invasive ventilation are commonly applied during endoscopic procedures. High flow oxygen therapy (HFOT) is a relatively novel device, still under-used in the context of interventional pulmonology, providing an humidified air-oxygen blend up to 60 L/min. HFOT has been reported to be effective for the treatment of both hypoxemic and hypercapnic respiratory failure. The investigators hypothesize that HFOT could be feasible and safe in patients undergoing bronchoscopy under moderate sedation, affected by or at risk of hypoxemic and/or hypercapnic respiratory failure.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: High Flow Oxygen Therapy (HFOT)
HFOT administration in patients undergoing bronchoscopy under moderate sedation, affected by or at risk of hypoxemic and/or hypercapnic respiratory failure.
Number of desaturation, defined as SpO2< 90 percent percent for >1 min, <5.
Time frame: one year
Percent of variation of pH, comparing ABG performed before bronchoscopy with that performed before partecipant's transferral to recovery room.
Time frame: one year
Percent of variation of PaCO2 variation, comparing ABG performed before bronchoscopy with that performed before partecipant's transferral to recovery room.
Time frame: one year
Rate of interruption of bronchoscopy because of number of desaturation, defined as SpO2< 90 percent for >1 min, >5.
Time frame: one year
Number of partecipants requiring an escalation of respiratory support.
Time frame: one year
Rate of new appearance of hemodynamic instability.
Time frame: one year
value of Charlson Comobidity Index associated with HFOT failure.
Time frame: one year
value of Body Mass Index associated with HFOT failure.
Time frame: one year
value of Borg dyspnea scale associated with HFOT failure.
Time frame: one year
Number of desaturations, defined as SpO2< 90 percent for >1 min.
Time frame: one year
Lowest oxygen saturation under HFOT.
Time frame: one year
Rate of change of HFOT parameters because of desaturation without respiratory acidosis.
Time frame: one year
Rate of change of HFOT parameters because of desaturation with respiratory acidosis
Time frame: one year
Start is estimated for Sep 2024; primary completion for Sep 2025, 12 months later.
Of 360 non-industry interventional studies with no phase under Respiratory Insufficiency, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 12 months is below that.
Counting every sponsor, half of 376 studies reached it within 24 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cardarelli Hospital